OD
Odyssey Therapeutics, Inc.
ODTX · NASDAQ
$23.06 -5.92% (-$1.45)
1M -3.06%
Valuation
-
N/A PEG N/A
P/S N/A
P/B N/A
Growth
-
N/A Rev. growth N/A
FCF growth N/A
Book val. growth N/A
Profitability
-
N/A Net margin N/A
Op. margin N/A
FCF margin N/A
Quality
-
N/A ROE N/A
ROA N/A
Asset turnover N/A
Debt
-
N/A Current ratio N/A
Int. coverage N/A
Net debt/EBITDA N/A
Stability
39 /100
Moderate Beta 1.43x
EPS volatility N/A
Profitable years N/A
Bulios Scoring descrie calitatea și istoricul unei companii, nu randamentul viitor. Un scor ridicat nu este un semnal de cumpărare. Află mai multe
Întreabă StockBot despre ODTX
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Gary D. Glick
Employees
100
Headquarters
Boston
Evenimente viitoare
04 NOV.
Earnings
Upcoming earnings report